Welcome to our dedicated page for AMC Robotics SEC filings (Ticker: AMCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMC Robotics's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMC Robotics's regulatory disclosures and financial reporting.
AMC Robotics Corp (AMCI) filed a prospectus supplement updating a resale registration covering up to 24,600,328 shares of Common Stock. These consist of 800,000 shares issued in PIPE Financing and 5,576,301 shares issuable upon exercise of PIPE warrants (together, the PIPE Shares), 2,224,027 shares held by former affiliates linked to the AlphaVest business combination, and 16,000,000 shares held by current affiliates. All registered shares may be sold from time to time by selling securityholders; the company will not receive proceeds from these resales.
AMC Robotics separately entered into warrant inducement agreements with two holders of existing warrants, who agreed to cash exercise warrants for up to 606,060 shares at a reduced exercise price of $1.65 per share, providing approximately $1.0 million in initial gross proceeds and up to an additional $1.1 million if remaining warrants are exercised. In exchange, the company will issue new inducement warrants to purchase up to 1,219,816 shares at an exercise price of $5.7756 per share, exercisable immediately and expiring in about four and one-third years. AMC Robotics plans to register the resale of the inducement warrant shares. AMCI last traded at $4.90 per share on Nasdaq on August 20, 2026.
AMC Robotics Corp (AMCI) entered into warrant inducement agreements with two investors to encourage the cash exercise of existing December 2025 warrants. The investors agreed to immediately exercise warrants to buy 606,060 shares of common stock at a reduced exercise price of $1.65 per share, generating $1 million in gross proceeds, and may exercise remaining warrants at the same price within 30 trading days for up to an additional $1.1 million.
In return, AMC Robotics will issue new unregistered warrants on a one-for-one basis for each share issued upon exercise, for up to 1,219,816 new warrant shares. These new warrants are immediately exercisable, carry a 25% premium to the prior-day closing share price, and expire four and one-third years after issuance. The company plans to use net proceeds to help fund its Vietnam robotics manufacturing facility, working capital, general corporate purposes, and product and services development. AMC Robotics will file a resale registration statement for the new warrant shares and agreed not to issue most other equity or file other registration statements (with limited exceptions) for 60 days after closing.
AMC Robotics Corporation (AMCI) filed a prospectus supplement covering the resale of up to 24,600,328 shares of common stock, including 800,000 PIPE shares, 5,576,301 shares underlying PIPE warrants, 2,224,027 AlphaVest-related shares, and 16,000,000 shares held by current affiliates. All sales are by selling securityholders; AMC Robotics will receive cash only if PIPE warrants are exercised. The supplement incorporates results for the quarter ended June 30, 2026, when revenue was $937,177 for the quarter and $2,121,793 for the first half, down from $3,189,800 a year earlier, but gross profit rose and first-half net loss narrowed sharply to $30,129. Cash and cash equivalents were $4.54 million with $0.92 million in total liabilities and operating cash outflow of $1.48 million in the first half. Revenue is highly concentrated, with related party Kami Vision representing 81% of first-half revenue and most related-party receivables.
AMC Robotics Corporation reported second quarter 2026 revenue of $937,177, down from $1,397,275 a year earlier as it intentionally reduced lower-margin product sales. Despite lower revenue, gross profit increased to $750,607 from $266,581, with gross margin expanding to 80% from 19% on a shift toward higher-margin AI, cloud, and service revenue, including revenue-sharing with related-party Kami Vision.
Operating loss narrowed significantly to $156,500 from $735,036, and net loss improved to $175,730 from $228,913, or ($0.01) per share in both periods. EBITDA loss also improved to $177,385 from $219,080. Cash and cash equivalents were $4,544,353 as of June 30, 2026, versus $7,004,601 at year-end 2025, reflecting $1,479,664 of operating cash outflow and a $1,000,000 strategic AI investment via SAFEs in Etronium AI Inc. Management highlights preparation for commercial launch of the NovaArm™ platform in the second half of 2026 and continued development of its AI-driven robotics ecosystem.
AMC Robotics Corporation reported for the three and six months ended June 30, 2026 that revenue declined to $937,177 and $2,121,793 from $1,397,275 and $3,189,800 a year earlier as hardware sales to related parties fell while revenue-share with Kami grew.
Despite lower revenue, gross profit increased to $1,771,263 from $754,912 for the six-month period as cost of revenues dropped sharply. The six‑month net loss narrowed to $30,129 versus $306,090, though operating activities used $1,479,664 of cash. Cash and cash equivalents were $4,544,353, down from $7,004,601 at December 31, 2025, after a $1,000,000 long‑term SAFE investment in Etronium AI Inc. The business remains highly dependent on related parties: Kami provided 81% of six‑month revenue and related parties supplied all inventory purchases over the period.
W. R. Berkley Corporation filed Amendment No. 1 to a Schedule 13G regarding Alphavest Acquisition Corp ordinary shares, par value $0.0001 per share (CUSIP G0283A108). The filing reports that W. R. Berkley Corporation and its subsidiary Berkley Insurance Company now beneficially own 0 shares, representing 0% of this class, with no sole or shared voting or dispositive power.
AMC Robotics Corporation amends its Form S-1 to add audited 2025 financials and to register the resale of up to 24,600,328 shares of Common Stock by selling securityholders. The registration covers (A) 6,376,301 PIPE-related shares (800,000 issued in the PIPE plus 5,576,301 underlying warrants), (B) 2,224,027 AlphaVest Affiliate Shares, and (C) 16,000,000 AMC Affiliate Shares. No new shares are being registered. The Company will receive proceeds only if the 5,576,301 warrants are exercised for cash at their stated exercise price, which, assuming cash exercise of all such warrants, could generate up to $22,400,000 of proceeds. The prospectus discloses a net loss of $24,926,364 for the year ended December 31, 2025 and identifies four material weaknesses in internal control. The Common Stock trades on Nasdaq under the symbol AMCI and 22,595,384 shares were outstanding as of July 8, 2026.
AMC Robotics Corporation signed a lease for a 6,150-square-meter manufacturing facility in Bắc Ninh, Vietnam to support Phase 1 production of its NovaArm robotic arm and future expansion of its robotics portfolio.
The facility will be operated by wholly owned subsidiary AMCV Company Limited and has been identified as a long-term hub for production and operations in Southeast Asia. AMC Robotics expects to invest approximately US$3.5 million in build-out and equipment through Phase 1, targeting completion of the facility build-out and production line commissioning with initial production in the second half of 2026. The plant is being configured with standardized precision assembly lines, whole-machine calibration, and automated end-of-line testing, and is intended later to support products such as the Kyro quadruped robotic dog.
AMC Robotics Corporation entered into two Simple Agreements for Future Equity (SAFEs) with Etronium AI Inc., investing a total of $1,000,000 through two separate $500,000 investments on April 7, 2026 and May 19, 2026. These SAFEs give AMC Robotics the right to receive Etronium equity if there is a future equity financing, liquidity event, or dissolution, under specified valuation caps and preference terms.
The companies describe Etronium’s agentic edge AI platform as improving hardware-in-the-loop workflows, with stated efficiency gains such as a 30-50% reduction in time-to-prototype and 40-60% lower integration effort, which AMC Robotics expects to support development of its Kyro and NovaArm robotic platforms.